PURPOSE: Monoclonal antibodies (mAbs) have been shown preclinically as reliable targeting moieties for antigen imaging using near-infrared fluorescence (NIRF) molecular imaging. However, crystallizable fragment-gamma receptor (FcγRs) expressed on immune cells also bind mAbs through defined epitopes on the constant fragment (Fc) of IgG. Herein, we evaluate the potential impact Fc interactions have on mAb agent imaging specificity. PROCEDURE: Through the removal of conserved glycans within the Fc domain, shown to have Fc/FcγR interactions, we evaluate their impact on non-specific binding/accumulation of a NIRF-labeled mAb-based imaging agent in lymph nodes (LNs) in inflamed animals and in an orthotopic prostate cancer animal model of LN metastasis. RESULTS: Deglycosylation of a murine mAb against the human epithelial cell adhesion marker using endoglycosidase EndoS significantly reduced non-specific binding in the LNs of inflamed animals and in cancer-negative LNs of tumor-bearing animals. Sensitivity remained unchanged while improvement in imaging specificity increased imaging accuracy. CONCLUSION: The reduction of non-specific binding through deglycosylation of a mAb-based imaging agent shows that reducing Fc/FcγR interactions can improve imaging accuracy.
PURPOSE: Monoclonal antibodies (mAbs) have been shown preclinically as reliable targeting moieties for antigen imaging using near-infrared fluorescence (NIRF) molecular imaging. However, crystallizable fragment-gamma receptor (FcγRs) expressed on immune cells also bind mAbs through defined epitopes on the constant fragment (Fc) of IgG. Herein, we evaluate the potential impact Fc interactions have on mAb agent imaging specificity. PROCEDURE: Through the removal of conserved glycans within the Fc domain, shown to have Fc/FcγR interactions, we evaluate their impact on non-specific binding/accumulation of a NIRF-labeled mAb-based imaging agent in lymph nodes (LNs) in inflamed animals and in an orthotopic prostate cancer animal model of LN metastasis. RESULTS: Deglycosylation of a murine mAb against the human epithelial cell adhesion marker using endoglycosidase EndoS significantly reduced non-specific binding in the LNs of inflamed animals and in cancer-negative LNs of tumor-bearing animals. Sensitivity remained unchanged while improvement in imaging specificity increased imaging accuracy. CONCLUSION: The reduction of non-specific binding through deglycosylation of a mAb-based imaging agent shows that reducing Fc/FcγR interactions can improve imaging accuracy.
Authors: A Krebber; S Bornhauser; J Burmester; A Honegger; J Willuda; H R Bosshard; A Plückthun Journal: J Immunol Methods Date: 1997-02-14 Impact factor: 2.303
Authors: Lakshmi Sampath; Sunkuk Kwon; Shi Ke; Wei Wang; Rachel Schiff; Michel E Mawad; Eva M Sevick-Muraca Journal: J Nucl Med Date: 2007-09 Impact factor: 10.057
Authors: Mikako Ogawa; Celeste A S Regino; Jurgen Seidel; Michael V Green; Wenze Xi; Mark Williams; Nobuyuki Kosaka; Peter L Choyke; Hisataka Kobayashi Journal: Bioconjug Chem Date: 2009-11 Impact factor: 4.774
Authors: Delphine Vivier; Sai Kiran Sharma; Pierre Adumeau; Cindy Rodriguez; Kimberly Fung; Brian M Zeglis Journal: J Nucl Med Date: 2019-02-07 Impact factor: 10.057
Authors: P B A A van Driel; M C Boonstra; H A J M Prevoo; M van de Giessen; T J A Snoeks; Q R J G Tummers; S Keereweer; R A Cordfunke; A Fish; J D H van Eendenburg; B P F Lelieveldt; J Dijkstra; C J H van de Velde; P J K Kuppen; A L Vahrmeijer; C W G M Löwik; C F M Sier Journal: BMC Cancer Date: 2016-11-14 Impact factor: 4.430
Authors: Kutty Selva Nandakumar; Mattias Collin; Kaisa E Happonen; Susanna L Lundström; Allyson M Croxford; Bingze Xu; Roman A Zubarev; Merrill J Rowley; Anna M Blom; Christian Kjellman; Rikard Holmdahl Journal: Front Immunol Date: 2018-07-16 Impact factor: 7.561
Authors: Delphine Vivier; Kimberly Fung; Cindy Rodriguez; Pierre Adumeau; Gary A Ulaner; Jason S Lewis; Sai Kiran Sharma; Brian M Zeglis Journal: Theranostics Date: 2020-01-01 Impact factor: 11.556